Connection

Barbara Tilley to Male

This is a "connection" page, showing publications Barbara Tilley has written about Male.
Connection Strength

0.756
  1. Analysis of transtheoretical model of health behavioral changes in a nutrition intervention study--a continuous time Markov chain model with Bayesian approach. Stat Med. 2015 Nov 30; 34(27):3577-89.
    View in: PubMed
    Score: 0.027
  2. Erythropoietin for traumatic brain injury--reply. JAMA. 2014 Nov 12; 312(18):1929.
    View in: PubMed
    Score: 0.026
  3. Enrollment of racially/ethnically diverse participants in traumatic brain injury trials: effect of availability of exception from informed consent. Clin Trials. 2014 Apr; 11(2):187-94.
    View in: PubMed
    Score: 0.025
  4. How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale. Mov Disord. 2013 May; 28(5):668-70.
    View in: PubMed
    Score: 0.023
  5. Calibration of unified Parkinson's disease rating scale scores to Movement Disorder Society-unified Parkinson's disease rating scale scores. Mov Disord. 2012 Sep 01; 27(10):1239-42.
    View in: PubMed
    Score: 0.022
  6. Examining the role of perceived susceptibility on colorectal cancer screening intention and behavior. Ann Behav Med. 2010 Oct; 40(2):205-17.
    View in: PubMed
    Score: 0.020
  7. Repeatable battery for assessment of neuropsychological status in early Parkinson's disease. Mov Disord. 2009 Jul 30; 24(10):1453-60.
    View in: PubMed
    Score: 0.018
  8. Retention of under-represented minorities in drug abuse treatment studies. Clin Trials. 2009 Jun; 6(3):252-60.
    View in: PubMed
    Score: 0.018
  9. Factor analysis of the Repeatable Battery for the Assessment of Neuropsychological Status. Appl Neuropsychol. 2008; 15(4):274-9.
    View in: PubMed
    Score: 0.016
  10. A coronary heart disease risk score based on patient-reported information. Am J Cardiol. 2007 May 01; 99(9):1236-41.
    View in: PubMed
    Score: 0.015
  11. Correlates and predictors of colorectal cancer screening among male automotive workers. Cancer Epidemiol Biomarkers Prev. 2007 Mar; 16(3):500-9.
    View in: PubMed
    Score: 0.015
  12. A study of lower extremity amputation rates in older diabetic South Carolinians. J S C Med Assoc. 2007 Feb; 103(1):4-7.
    View in: PubMed
    Score: 0.015
  13. English language skills and diabetes and hypertension among foreign-born South Asian adults in England. Public Health Rep. 2006 May-Jun; 121(3):331-6.
    View in: PubMed
    Score: 0.014
  14. Development of a measure to assess patient trust in medical researchers. Ann Fam Med. 2006 May-Jun; 4(3):247-52.
    View in: PubMed
    Score: 0.014
  15. Demographic and clinical factors associated with in-hospital death among patients with systemic sclerosis. J Rheumatol. 2005 Oct; 32(10):1888-92.
    View in: PubMed
    Score: 0.014
  16. Race, education, and knowledge of bone marrow registry: indicators of willingness to donate bone marrow among African Americans and Caucasians. Transplant Proc. 2004 Dec; 36(10):3212-9.
    View in: PubMed
    Score: 0.013
  17. A pilot study of health education via a nurse-run telephone self-management programme for elderly people with osteoarthritis. J Telemed Telecare. 2004; 10(1):44-9.
    View in: PubMed
    Score: 0.012
  18. Intention to be screened over time for colorectal cancer in male automotive workers. Cancer Epidemiol Biomarkers Prev. 2003 Apr; 12(4):339-49.
    View in: PubMed
    Score: 0.012
  19. Recruiting older African American men to a cancer screening trial (the AAMEN Project). Gerontologist. 2003 Feb; 43(1):27-35.
    View in: PubMed
    Score: 0.012
  20. Perceptions of diabetes among patients in an urban health care system. Ethn Health. 2002 Nov; 7(4):243-54.
    View in: PubMed
    Score: 0.011
  21. Recruitment of African Americans with type 2 diabetes to a randomized controlled trial using three sources. Ethn Health. 2002 Nov; 7(4):267-78.
    View in: PubMed
    Score: 0.011
  22. Cost-effectiveness evaluation of the PROPPR trial transfusion protocols. Transfusion. 2020 05; 60(5):922-931.
    View in: PubMed
    Score: 0.010
  23. Global statistical tests for comparing multiple outcomes in rheumatoid arthritis trials. MIRA Trial Group. Arthritis Rheum. 1999 Sep; 42(9):1879-88.
    View in: PubMed
    Score: 0.009
  24. The Next Step Trial: impact of a worksite colorectal cancer screening promotion program. Prev Med. 1999 Mar; 28(3):276-83.
    View in: PubMed
    Score: 0.009
  25. Nutrition intervention for high-risk auto workers: results of the Next Step Trial. Prev Med. 1999 Mar; 28(3):284-92.
    View in: PubMed
    Score: 0.009
  26. Racial differences in emergency department use persist despite allergist visits and prescriptions filled for antiinflammatory medications. J Allergy Clin Immunol. 1998 Apr; 101(4 Pt 1):484-90.
    View in: PubMed
    Score: 0.008
  27. Development and validation of an instrument to measure factors related to colorectal cancer screening adherence. Cancer Epidemiol Biomarkers Prev. 1997 Oct; 6(10):825-32.
    View in: PubMed
    Score: 0.008
  28. Validation of the Hebrew version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale. Parkinsonism Relat Disord. 2017 Dec; 45:7-12.
    View in: PubMed
    Score: 0.008
  29. Benefits of stroke treatment delivered using a mobile stroke unit trial. Int J Stroke. 2018 04; 13(3):321-327.
    View in: PubMed
    Score: 0.008
  30. Comparison of laboratory test frequency and test results between African-Americans and Caucasians with diabetes: opportunity for improvement. Findings from a large urban health maintenance organization. Diabetes Care. 1997 Jun; 20(6):971-7.
    View in: PubMed
    Score: 0.008
  31. Autonomic and electrocardiographic findings in Parkinson's disease. Auton Neurosci. 2017 07; 205:93-98.
    View in: PubMed
    Score: 0.008
  32. Worksite cancer screening and nutrition intervention for high-risk auto workers: design and baseline findings of the Next Step Trial. Prev Med. 1997 Mar-Apr; 26(2):227-35.
    View in: PubMed
    Score: 0.008
  33. Damage control laparotomy utilization rates are highly variable among Level I trauma centers: Pragmatic, Randomized Optimal Platelet and Plasma Ratios findings. J Trauma Acute Care Surg. 2017 03; 82(3):481-488.
    View in: PubMed
    Score: 0.008
  34. Caffeine, creatine, GRIN2A and Parkinson's disease progression. J Neurol Sci. 2017 Apr 15; 375:355-359.
    View in: PubMed
    Score: 0.008
  35. Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson's Disease: An?Analysis?of?NET-PD LS1. J Parkinsons Dis. 2017; 7(1):117-127.
    View in: PubMed
    Score: 0.008
  36. Gender-, age-, and race/ethnicity-based differential item functioning analysis of the movement disorder society-sponsored revision of the Unified Parkinson's disease rating scale. Mov Disord. 2016 12; 31(12):1865-1873.
    View in: PubMed
    Score: 0.007
  37. Religiosity in black and white older Americans: Measure adaptation, psychometric validation, and racial difference. Medicine (Baltimore). 2016 Sep; 95(37):e4257.
    View in: PubMed
    Score: 0.007
  38. Two Decades of ICU Utilization and Hospital Outcomes in a Comprehensive Cancer Center. Crit Care Med. 2016 May; 44(5):926-33.
    View in: PubMed
    Score: 0.007
  39. Damage-control resuscitation and emergency laparotomy: Findings from the PROPPR study. J Trauma Acute Care Surg. 2016 Apr; 80(4):568-74; discussion 574-5.
    View in: PubMed
    Score: 0.007
  40. The incidence of ARDS and associated mortality in severe TBI using the Berlin definition. J Trauma Acute Care Surg. 2016 Feb; 80(2):308-12.
    View in: PubMed
    Score: 0.007
  41. Association of transfusion red blood cell storage age and blood oxygenation, long-term neurologic outcome, and mortality in traumatic brain injury. J Trauma Acute Care Surg. 2015 Nov; 79(5):843-9.
    View in: PubMed
    Score: 0.007
  42. Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio. Cerebrovasc Dis. 2015; 40(5-6):293-300.
    View in: PubMed
    Score: 0.007
  43. Caffeine and Progression of Parkinson Disease: A Deleterious Interaction With Creatine. Clin Neuropharmacol. 2015 Sep-Oct; 38(5):163-9.
    View in: PubMed
    Score: 0.007
  44. Place of Death among Hospitalized Patients with Cancer at the End of Life. J Palliat Med. 2015 Aug; 18(8):667-76.
    View in: PubMed
    Score: 0.007
  45. Making thawed universal donor plasma available rapidly for massively bleeding trauma patients: experience from the Pragmatic, Randomized Optimal Platelets and Plasma Ratios (PROPPR) trial. Transfusion. 2015 Jun; 55(6):1331-9.
    View in: PubMed
    Score: 0.007
  46. Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial. JAMA. 2015 Feb 10; 313(6):584-93.
    View in: PubMed
    Score: 0.007
  47. Handling missing values in the MDS-UPDRS. Mov Disord. 2015 Oct; 30(12):1632-8.
    View in: PubMed
    Score: 0.007
  48. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015 Feb 03; 313(5):471-82.
    View in: PubMed
    Score: 0.007
  49. Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group. Ann Intern Med. 1995 Jan 15; 122(2):81-9.
    View in: PubMed
    Score: 0.007
  50. An evaluation of differences in risk factors for individual types of surgical site infections after colon surgery. Surgery. 2014 Nov; 156(5):1253-60.
    View in: PubMed
    Score: 0.006
  51. Relationships among cognitive impairment, sleep, and fatigue in Parkinson's disease using the MDS-UPDRS. Parkinsonism Relat Disord. 2014 Nov; 20(11):1135-9.
    View in: PubMed
    Score: 0.006
  52. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014 Nov 29; 384(9958):1929-35.
    View in: PubMed
    Score: 0.006
  53. Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial. JAMA. 2014 Jul 02; 312(1):36-47.
    View in: PubMed
    Score: 0.006
  54. Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial: design, rationale and implementation. Injury. 2014 Sep; 45(9):1287-95.
    View in: PubMed
    Score: 0.006
  55. Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience. JAMA Neurol. 2014 Jun; 71(6):710-6.
    View in: PubMed
    Score: 0.006
  56. Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients. Eur J Neurol. 2014 Mar; 21(3):519-24.
    View in: PubMed
    Score: 0.006
  57. The MDS-UPDRS Part II (motor experiences of daily living) resulted useful for assessment of disability in Parkinson's disease. Parkinsonism Relat Disord. 2013 Oct; 19(10):889-93.
    View in: PubMed
    Score: 0.006
  58. Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale. Eur J Neurol. 2015 Jan; 22(1):37-43.
    View in: PubMed
    Score: 0.006
  59. Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS). J Neurol. 2013 Jan; 260(1):228-36.
    View in: PubMed
    Score: 0.006
  60. Validation of the Italian version of the Movement Disorder Society--Unified Parkinson's Disease Rating Scale. Neurol Sci. 2013 May; 34(5):683-7.
    View in: PubMed
    Score: 0.006
  61. Subject-investigator reproducibility of the Unified Parkinson's Disease Rating Scale. Parkinsonism Relat Disord. 2012 Mar; 18(3):230-3.
    View in: PubMed
    Score: 0.005
  62. Application of beta regression to analyze ischemic stroke volume in NINDS rt-PA clinical trials. Neuroepidemiology. 2011; 37(2):73-82.
    View in: PubMed
    Score: 0.005
  63. Impact of belief in neuroprotection on therapeutic intervention in Parkinson's disease. Mov Disord. 2010 Jun 15; 25(8):1082-6.
    View in: PubMed
    Score: 0.005
  64. Risk of colorectal cancer among automotive pattern and model makers. J Occup Med. 1990 Jun; 32(6):541-6.
    View in: PubMed
    Score: 0.005
  65. A meta-analysis of exposure to phenoxy acid herbicides and chlorophenols in relation to risk of soft tissue sarcoma. Int Arch Occup Environ Health. 1990; 62(7):513-20.
    View in: PubMed
    Score: 0.005
  66. Determinants of the timing of symptomatic treatment in early Parkinson disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience. Arch Neurol. 2009 Sep; 66(9):1099-104.
    View in: PubMed
    Score: 0.005
  67. Patent foramen ovale, cardiac valve thickening, and antiphospholipid antibodies as risk factors for subsequent vascular events: the PICSS-APASS study. Stroke. 2009 Jul; 40(7):2337-42.
    View in: PubMed
    Score: 0.004
  68. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008 Nov 15; 23(15):2129-70.
    View in: PubMed
    Score: 0.004
  69. Caffeine and progression of Parkinson disease. Clin Neuropharmacol. 2008 Jul-Aug; 31(4):189-96.
    View in: PubMed
    Score: 0.004
  70. Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study. Stroke. 2006 Oct; 37(10):2508-13.
    View in: PubMed
    Score: 0.004
  71. Racial variation in clinical and immunological manifestations of systemic sclerosis. J Rheumatol. 2006 Feb; 33(2):263-8.
    View in: PubMed
    Score: 0.004
  72. Acculturation and diabetes among Hispanics: evidence from the 1999-2002 National Health and Nutrition Examination Survey. Public Health Rep. 2006 Jan-Feb; 121(1):60-6.
    View in: PubMed
    Score: 0.004
  73. Nonprescribed antimicrobial drugs in Latino community, South Carolina. Emerg Infect Dis. 2005 Jun; 11(6):883-8.
    View in: PubMed
    Score: 0.003
  74. Clinical trials: II. Randomization and sample size. Henry Ford Hosp Med J. 1985; 33(4):219-24.
    View in: PubMed
    Score: 0.003
  75. Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis. J Rheumatol. 2005 Jan; 32(1):51-7.
    View in: PubMed
    Score: 0.003
  76. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004 Mar 06; 363(9411):768-74.
    View in: PubMed
    Score: 0.003
  77. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA. 2004 Feb 04; 291(5):576-84.
    View in: PubMed
    Score: 0.003
  78. An assessment of racial differences in clinical practices for hypertension at primary care sites for medically underserved patients. J Clin Hypertens (Greenwich). 2004 Jan; 6(1):26-31; quiz 32-3.
    View in: PubMed
    Score: 0.003
  79. Pilot clinical trial of intravenous doxycycline versus placebo for rheumatoid arthritis. J Rheumatol. 2003 Jan; 30(1):41-3.
    View in: PubMed
    Score: 0.003
  80. Predicting prognosis after stroke: a placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial. Neurology. 2000 Oct 10; 55(7):952-9.
    View in: PubMed
    Score: 0.002
  81. Mediating factors in dietary change: understanding the impact of a worksite nutrition intervention. Health Educ Behav. 2000 Feb; 27(1):112-25.
    View in: PubMed
    Score: 0.002
  82. Nurses' perceptions: issues that arise in caring for patients with diabetes. J Adv Nurs. 1999 Aug; 30(2):425-30.
    View in: PubMed
    Score: 0.002
  83. Self-administered joint counts and standard joint counts in the assessment of rheumatoid arthritis. MIRA Trial Group. Minocycline in RA. J Rheumatol. 1999 May; 26(5):1065-7.
    View in: PubMed
    Score: 0.002
  84. Lower thrombolytic use for African Americans with myocardial infarction: an influence of clinical presentation? Am Heart J. 1999 Feb; 137(2):338-45.
    View in: PubMed
    Score: 0.002
  85. A comparison of asthma-related healthcare use between African-Americans and Caucasians belonging to a health maintenance organization (HMO). J Asthma. 1999; 36(2):195-204.
    View in: PubMed
    Score: 0.002
  86. Social support among African-American adults with diabetes, Part 2: A review. J Natl Med Assoc. 1998 Jul; 90(7):425-32.
    View in: PubMed
    Score: 0.002
  87. Social support among African-American adults with diabetes. Part 1: Theoretical framework. J Natl Med Assoc. 1998 Jun; 90(6):361-5.
    View in: PubMed
    Score: 0.002
  88. Intention to screen for colorectal cancer among white male employees. Prev Med. 1998 Mar-Apr; 27(2):279-87.
    View in: PubMed
    Score: 0.002
  89. Psychosocial correlates of healthful diets among male auto workers. Cancer Epidemiol Biomarkers Prev. 1998 Feb; 7(2):119-26.
    View in: PubMed
    Score: 0.002
  90. Health outcomes among African American and Caucasian adults following a randomized trial of an asthma education program. Ethn Health. 1997 Nov; 2(4):329-39.
    View in: PubMed
    Score: 0.002
  91. A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis Trial Group. J Rheumatol. 1997 Oct; 24(10):1910-5.
    View in: PubMed
    Score: 0.002
  92. Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) Trial. J Rheumatol. 1997 Jul; 24(7):1295-302.
    View in: PubMed
    Score: 0.002
  93. Meaningful improvement criteria sets in a rheumatoid arthritis clinical trial. MIRA Trial Group. Minocycline in Rheumatoid Arthritis. Arthritis Rheum. 1997 Mar; 40(3):419-25.
    View in: PubMed
    Score: 0.002
  94. Rib enlargement in patients with chronic pleural disease. AJR Am J Roentgenol. 1996 Oct; 167(4):921-6.
    View in: PubMed
    Score: 0.002
  95. Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region. Genes Chromosomes Cancer. 1994 Mar; 9(3):192-206.
    View in: PubMed
    Score: 0.002
  96. Prognostic significance of electrocardiographic persistent ST depression in patients with their first myocardial infarction in the placebo arm of the Beta-Blocker Heart Attack Trial. Am Heart J. 1993 Aug; 126(2):271-8.
    View in: PubMed
    Score: 0.001
  97. Age-related changes in glomerular volume and hydroxyproline content in rat and human. J Am Soc Nephrol. 1992 Jun; 2(12):1716-25.
    View in: PubMed
    Score: 0.001
  98. The cost and effectiveness of an education program for adults who have asthma. J Gen Intern Med. 1991 Sep-Oct; 6(5):401-7.
    View in: PubMed
    Score: 0.001
  99. Effects of propranolol in non-Q-wave acute myocardial infarction in the beta blocker heart attack trial. Am J Cardiol. 1990 Jul 15; 66(2):129-33.
    View in: PubMed
    Score: 0.001
  100. Effects of cigarette smoking and propranolol in survivors of acute myocardial infarction. Am J Cardiol. 1990 Feb 01; 65(5):271-6.
    View in: PubMed
    Score: 0.001
  101. Risk identification at the time of admission to coronary care unit in patients with suspected myocardial infarction. Am Heart J. 1988 Nov; 116(5 Pt 1):1212-7.
    View in: PubMed
    Score: 0.001
  102. Recurrent femoral anastomotic aneurysms. A 30-year experience. Ann Surg. 1988 Oct; 208(4):401-9.
    View in: PubMed
    Score: 0.001
  103. Frequency and significance of cardiac arrhythmias in chronic obstructive lung disease. Chest. 1988 Jul; 94(1):44-8.
    View in: PubMed
    Score: 0.001
  104. Cerebral blood flow asymmetry in the detection of extracranial cerebrovascular disease. Stroke. 1988 Jul; 19(7):813-9.
    View in: PubMed
    Score: 0.001
  105. Efficacy of propranolol therapy after acute myocardial infarction related to coronary arterial anatomy and left ventricular function. Am J Cardiol. 1987 Nov 01; 60(13):976-80.
    View in: PubMed
    Score: 0.001
  106. The porcine bioprosthetic valve. Twelve years later. J Thorac Cardiovasc Surg. 1985 Apr; 89(4):499-507.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.